Your browser doesn't support javascript.
loading
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening.
Leroux, Florence; Bosc, Damien; Beghyn, Terence; Hermant, Paul; Warenghem, Sandrine; Landry, Valérie; Pottiez, Virginie; Guillaume, Valentin; Charton, Julie; Herledan, Adrien; Urata, Sarah; Liang, Wenguang; Sheng, Li; Tang, Wei-Jen; Deprez, Benoit; Deprez-Poulain, Rebecca.
Afiliação
  • Leroux F; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France.
  • Bosc D; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France.
  • Beghyn T; APTEEUS, F-59000, Lille, France.
  • Hermant P; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France.
  • Warenghem S; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France.
  • Landry V; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France.
  • Pottiez V; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France.
  • Guillaume V; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France.
  • Charton J; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France; European Genomic Institute for Diabetes, EGID, University of Lille, F-59000, France.
  • Herledan A; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France.
  • Urata S; Department of Medicine, University of California at San Diego, CA 92093, La Jolla, United States.
  • Liang W; Ben-May Institute for Cancer Research, The University of Chicago, IL 60637, Chicago, United States.
  • Sheng L; Department of Medicine, University of California at San Diego, CA 92093, La Jolla, United States.
  • Tang WJ; Ben-May Institute for Cancer Research, The University of Chicago, IL 60637, Chicago, United States.
  • Deprez B; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France; APTEEUS, F-59000, Lille, France; European Genomic Institute for Diabetes, EGID, University of Lille, F-59000, France.
  • Deprez-Poulain R; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France; European Genomic Institute for Diabetes, EGID, University of Lille, F-59000, France; Institut Universitaire de France, F- 75231, Paris, France. Electronic address: rebecca.deprez@un
Eur J Med Chem ; 179: 557-566, 2019 Oct 01.
Article em En | MEDLINE | ID: mdl-31276900
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azóis / Compostos Organosselênicos / Inibidores Enzimáticos / Reposicionamento de Medicamentos / Insulisina Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azóis / Compostos Organosselênicos / Inibidores Enzimáticos / Reposicionamento de Medicamentos / Insulisina Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article